{"id":8189,"date":"2025-03-27T16:22:51","date_gmt":"2025-03-27T16:22:51","guid":{"rendered":"https:\/\/www.ixa.nl\/story\/verhaal-van-arjan-griffioen-amsterdam-umc\/"},"modified":"2026-08-26T08:10:37","modified_gmt":"2026-08-26T08:10:37","slug":"arjan-griffioen","status":"publish","type":"story","link":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/","title":{"rendered":"Story of Arjan Griffioen (Amsterdam UMC)"},"excerpt":{"rendered":"<p>Wetenschapper Arjan Griffioen leidt een innovatie kankerbehandeling met lab en startup (Amsterdam UMC). Kan een innovatieve behandeling tegen kanker worden gebruikt als preventief vaccin? Arjan Griffioen en zijn team zijn vastbesloten dat uit te zoeken.<\/p>\n","protected":false},"featured_media":12424,"template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","inline_featured_image":false},"categories":[],"tags":[],"knowledge-institution":[],"ixa_theme":[],"class_list":["post-8189","story","type-story","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Story of Arjan Griffioen (Amsterdam UMC) - IXA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Story of Arjan Griffioen (Amsterdam UMC) - IXA\" \/>\n<meta property=\"og:description\" content=\"Wetenschapper Arjan Griffioen leidt een innovatie kankerbehandeling met lab en startup (Amsterdam UMC). Kan een innovatieve behandeling tegen kanker worden gebruikt als preventief vaccin? Arjan Griffioen en zijn team zijn vastbesloten dat uit te zoeken.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/\" \/>\n<meta property=\"og:site_name\" content=\"IXA\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-26T08:10:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ixa.nl\/app\/uploads\/2025\/03\/startscherm_IXA_Valorisatie_ArjanGriffioen.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/story\\\/arjan-griffioen\\\/\",\"url\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/story\\\/arjan-griffioen\\\/\",\"name\":\"Story of Arjan Griffioen (Amsterdam UMC) - IXA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/story\\\/arjan-griffioen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/story\\\/arjan-griffioen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ixa.nl\\\/app\\\/uploads\\\/2025\\\/03\\\/startscherm_IXA_Valorisatie_ArjanGriffioen.jpg\",\"datePublished\":\"2025-03-27T16:22:51+00:00\",\"dateModified\":\"2026-08-26T08:10:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/story\\\/arjan-griffioen\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/story\\\/arjan-griffioen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/story\\\/arjan-griffioen\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ixa.nl\\\/app\\\/uploads\\\/2025\\\/03\\\/startscherm_IXA_Valorisatie_ArjanGriffioen.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ixa.nl\\\/app\\\/uploads\\\/2025\\\/03\\\/startscherm_IXA_Valorisatie_ArjanGriffioen.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/story\\\/arjan-griffioen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Story of Arjan Griffioen (Amsterdam UMC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/#website\",\"url\":\"https:\\\/\\\/www.ixa.nl\\\/\",\"name\":\"IXA\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ixa.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Story of Arjan Griffioen (Amsterdam UMC) - IXA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/","og_locale":"nl_NL","og_type":"article","og_title":"Story of Arjan Griffioen (Amsterdam UMC) - IXA","og_description":"Wetenschapper Arjan Griffioen leidt een innovatie kankerbehandeling met lab en startup (Amsterdam UMC). Kan een innovatieve behandeling tegen kanker worden gebruikt als preventief vaccin? Arjan Griffioen en zijn team zijn vastbesloten dat uit te zoeken.","og_url":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/","og_site_name":"IXA","article_modified_time":"2026-08-26T08:10:37+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.ixa.nl\/app\/uploads\/2025\/03\/startscherm_IXA_Valorisatie_ArjanGriffioen.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/","url":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/","name":"Story of Arjan Griffioen (Amsterdam UMC) - IXA","isPartOf":{"@id":"https:\/\/www.ixa.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/#primaryimage"},"image":{"@id":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ixa.nl\/app\/uploads\/2025\/03\/startscherm_IXA_Valorisatie_ArjanGriffioen.jpg","datePublished":"2025-03-27T16:22:51+00:00","dateModified":"2026-08-26T08:10:37+00:00","breadcrumb":{"@id":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/#primaryimage","url":"https:\/\/www.ixa.nl\/app\/uploads\/2025\/03\/startscherm_IXA_Valorisatie_ArjanGriffioen.jpg","contentUrl":"https:\/\/www.ixa.nl\/app\/uploads\/2025\/03\/startscherm_IXA_Valorisatie_ArjanGriffioen.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.ixa.nl\/nl\/story\/arjan-griffioen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ixa.nl\/nl\/homepage\/"},{"@type":"ListItem","position":2,"name":"Story of Arjan Griffioen (Amsterdam UMC)"}]},{"@type":"WebSite","@id":"https:\/\/www.ixa.nl\/#website","url":"https:\/\/www.ixa.nl\/","name":"IXA","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ixa.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"}]}},"_links":{"self":[{"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/story\/8189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/story"}],"about":[{"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/types\/story"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/media\/12424"}],"wp:attachment":[{"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/media?parent=8189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/categories?post=8189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/tags?post=8189"},{"taxonomy":"knowledge-institution","embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/knowledge-institution?post=8189"},{"taxonomy":"ixa_theme","embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/ixa_theme?post=8189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}